Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma.

Morschhauser, F; Depil, S; Jourdan, E; Wetterwald, M; Bouabdallah, R; Marit, G; Solal-Céligny, P; Sebban, C; Coiffier, B; Chouaki, N; Bauters, F; Dumontet, C

Morschhauser, F; Depil, S; Jourdan, E; Wetterwald, M; Bouabdallah, R; Marit, G; Solal-Céligny, P; Sebban, C; Coiffier, B; Chouaki, N; Bauters, F; Dumontet, C.

Affiliation

Morschhauser F; Service des Maladies du Sang, Lille, France.

Ann Oncol ; 18(2): 370-5, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17074972

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Lymphoma, Mantle-Cell/drug therapy; Neoplasm Recurrence, Local/drug therapy; Adult; Aged; Cisplatin/administration & dosage; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Dexamethasone/administration & dosage; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Mantle-Cell/metabolism; Male; Middle Aged; Remission Induction; Salvage Therapy; Treatment Outcome; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Mantle-Cell / Neoplasm Recurrence, Local Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2007 Document type: Article Affiliation country: France Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links